Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Aspen Aerogels (ASPN) over the last 6 years, with Q3 2025 value amounting to -$2000.0.

  • Aspen Aerogels' Asset Writedowns and Impairment changed N/A to -$2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $288.8 million, marking a year-over-year increase of 412563.28%. This contributed to the annual value of $7.6 million for FY2024, which is 828602.15% up from last year.
  • As of Q3 2025, Aspen Aerogels' Asset Writedowns and Impairment stood at -$2000.0.
  • Aspen Aerogels' 5-year Asset Writedowns and Impairment high stood at $286.6 million for Q1 2025, and its period low was -$171000.0 during Q2 2023.
  • For the 5-year period, Aspen Aerogels' Asset Writedowns and Impairment averaged around $18.5 million, with its median value being $29000.0 (2021).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first tumbled by 437500.0% in 2023, then surged by 2017500.0% in 2024.
  • Quarter analysis of 5 years shows Aspen Aerogels' Asset Writedowns and Impairment stood at $15000.0 in 2021, then surged by 386.67% to $73000.0 in 2022, then plummeted by 105.48% to -$4000.0 in 2023, then skyrocketed by 20175.0% to $803000.0 in 2024, then plummeted by 100.25% to -$2000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$2000.0 in Q3 2025, compared to $1.4 million in Q2 2025 and $286.6 million in Q1 2025.